drugset / Trial / NCT06663618

Short-term Glucocorticoid Combined with MMF for IgG4-RD

NCT06663618

Recruiting 63 enrolled Wen Zhang
RandomizedParallel-groupOpen-labelTreatment

Summary

Comparison of short-term glucocorticoid monotherapy and short-term glucocorticoid combined with MMF in the treatment of IgG4 Related Disease

Timeline

Start
2023-09-01
Primary completion
2025-03-01
Completion
2025-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mycophenolate Mofetil Small molecule 0.75 g Oral
Background Prednisone Other / unclassified 0.6 mg/kg Oral
Background Prednisone Other / unclassified 0.8 mg/kg Oral